chrisvoncsefalvay/vaers-outcomes huggingface dataset:
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/30/2021 DM 2 W UNSPECIFIED COMPLICATION
Right arm pain, numbness up to neck. Right side of facial numbness and headache numbness of hands/fingers. Pain radiated down arm.
Weakness in legs and arms; Not felt good since then; No energy; Headache; Aches all over; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in legs and arms), FEELING ABNORMAL (Not felt good since then), ASTHENIA (No energy), HEADACHE (Headache) and MYALGIA (Aches all over) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced FEELING ABNORMAL (Not felt good since then), ASTHENIA (No energy), HEADACHE (Headache) and MYALGIA (Aches all over). On an unknown date, the patient experienced MUSCULAR WEAKNESS (Weakness in legs and arms). At the time of the report, MUSCULAR WEAKNESS (Weakness in legs and arms) had not resolved and FEELING ABNORMAL (Not felt good since then), ASTHENIA (No energy), HEADACHE (Headache) and MYALGIA (Aches all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The first 2 days after the vaccine, she had aches all over,headache and no energy.She later felt better.  No relevant concomitant medications were reported.  No treatment information was provided.
Pt recvd Hep B vax & lab eval revealed pos Hep B core antibody equivalent to Hep C; No further details were reported;
hair loss; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "hair loss". Additional information: the patient reported he experienced hair loss since taking your COVID vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient is experiencing weakness in left arm (where injection was given) and is unable to lift up her arm and range of motion of her shoulder is limited. She can wiggle her fingers and move it, but less than normal. It is very painful (10 on 1-10 pain scale). It is not visually swollen, but started 5 hours after the flu shot and is continuing as of now.
pt recvd vax & 3 days later pt devel swelling, warmth, & redness @ the inject site
Mom reports increased fussiness and crying for 5 hours, beginning 1/2 hour post vax. No fever, erythema or swelling of injection site.
Fever, pain throughout body, chills, extremly tired, headache, body aches. no appetite. Asthma flared up with cough, tight chest, hard to breathe .went to Dr next day was put on prednsione as all other aliments went away except asthma. Have been using symbicort, prednisone, 3 seperate prescriptions ,  Z Pack, albuterol. cough medicine DM , claritin, nebulizer and nothing is clearing up the breathing or coughing spells.
Patient received both comirnaty covid and flublok quad.  After receiving the vaccine he felt light headed, dizzy, sweaty and passed out or had a seizure.  The EMT was called.  Patient did come too on his own but EMT was called to check him out.  He was experiencing low blood pressure and EMT choose to take him to the hospital.
felt achy; flu like; some arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a (RA). The reporter is the patient. A female patient received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "felt achy"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu like"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "some arm pain".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore). On 19-Feb-2021, PAIN IN EXTREMITY (arm was a little sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient is the spouse of an Active Duty Service member who was given the Smallpox Vaccine on 26OCT2011. The patient developed a similar sore to that of her husband more than 1 week later. She states that he did keep it clean and covered as instructed, but they share bed sheets, towels, etc. Now the patient has a typical "major reaction" to a smallpox vaccine on her Right Forearm.
This spontaneous report was received from a medical assistant concerning to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 21-NOV-2015, the patient was vaccinated with improperly stored ROTATEQ oral liquid, lot # K022995, expiration date 22-JUL-2016, (dose and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Started to experience pins & needles feeling in my chest which spread to my extremities. Then had trouble breathing and felt tightness in my throat. Lasted about 5 to 6 min.
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: when i gave pt the second dose she forgot to tell me that when she had the first shot she had hives at the back of her knee. It was very mild that she forgot to tell me thats why i gave her 2nd shot. She was ok. Once she applied hydrocortisone she was fine. She got hives again after the second shot and shw did the same treatment. She is fine.
Information has been received from a health professional concerning a 15 month old male pt who on 19Sep03 was vaccinated with the first dose of measles virus vaccine live (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot #641624/0126M), subcutaneously in the right arm. On 30Sep03, "9 days post vaccination", the pt developed urticaria over his entire body. The pt's urticaria responded to diphenhydramine (Benadryl). On 02Oct03, the pt recovered. It was reported that the pt had no illnesses at the time of vaccination. Additional information has been requested.
Initial report was received from another manufacturer who received the report from a consumer, who was also the patient, on 12 March 2012 under reference number S2012US01089. A 47-year-old male patient had received an injection of FLUZONE (lot number, route and site not reported) on 18 October 2011 and an unspecified amount of time later developed rash, eye swelling, nausea and vomiting (N&V), delirious, irrational, heart raced and "felt like he was going to die." The patient went to the emergency room (ER) and was treated. Laboratory results included creatinine 2.7 and blood pressure (BP) 182-190. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: None.
Left arm swelled in size, site of injection was red, irritated, and painful to touch. Redness spread down left bicep to below elbow.
Day after injection, experienced mild joint pain in shoulder, elbow, and wrist of arm injected. Symptoms persisted for several weeks. Upon receiving second injection on April 29th, symptoms became worse, including muscular weakness, numbness in thumb, forefinger, and middle finger of arm receiving injection. Symptoms persisted throughout 2021. During routine physical in Nov 2021, reported symptoms to primary care physician. Physician diagnosed suspected damage to median nerve typical of carpal tunnel syndrome. Performed tests to diagnose carpal tunnel syndrome, symptoms not consistent with carpel tunnel syndrome. Symptoms persist in Jan 2022. Primary care physician encouraged submitting VAERS report.
Patient started with red, itchy rash on chest and arms starting approximately one hour after immunizations. Rash spread and grew more itchy through today. IV Solumedrol give in the office. Patient sent home on Prednisone, Loratadine, and Ranitidine.
Within two hours, swelling and sore arm, numbness in arm. The extreme soreness and numbness continues to this day. I never have had this happen before - to last over a year from a vaccination. In addition, I suffered a stroke on June 14, 2022 which required hospitalization. After leaving the hospital I was recovering at my son's home for months before returning to my home. I still have lingering symptoms from the stroke in addition to the extremely sore arm and numbness.
soreness; tenderness; Swelling; heat; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), VACCINATION SITE PAIN (tenderness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE WARMTH (heat) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness), VACCINATION SITE PAIN (tenderness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE WARMTH (heat) and PYREXIA (fever). At the time of the report, PAIN (soreness), VACCINATION SITE PAIN (tenderness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE WARMTH (heat) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
chills; body aches; This is a spontaneous report from a contactable consumer. A male patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 11Mar2021, the patient experienced chills and body aches. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events chills and body aches was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On 7/23/2021 I began to have pelvic/uterine pain and pressure on and off - not normal for me. This continued the next few days - aching, uncomfortable twinges in my ovaries. Called ob/gyn and made an appt. Ultrasound was ordered to check for cysts, PCOS etc...nothing was found on the ultrasound. Continued with the pain and pressure - especially when I ovulated that month. My next period was extremely heavy - not normal for me - and it last longer than usual. My next period in Sept. was extremely painful - painful cramps and pressure throughout my period where I had to take Advil around the clock to help with the pain and pressure.
The nest morning when I woke up I felt like I had been hit by a truck. Every part of my body ached. Took monumental effort to get out of bed. Had a headache, felt just terrible. Stayed in bed for the day. It got better over the next several days so I could function. The joint pain got a little better but never really went away. Many of my joints still ache, wrists, fingers, ankles, not hurting enough to keep me in bed. But enough to feel different from before I had the shot. Was afraid to go to the doctor because there  was a high rate of COVID in her immediate area so I was concerned about going to a hospital or something.
Pneumo vac & flu vaccine given on 9/21/10 pt's appt was 3 pm. Later that evening pt experienced moderately severe pain. Swelling & burning. On 9/22 pt had fever & nausea DEPO MEDROL 80mg injected. PHENERGAN 25mg.
This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's past medical history included left lobectomy with 20 percent removal of left lung. The patient had no known allergies and was a very healthy individual with a little more risk than the normal person. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) 1 total, dose was not reported, administered on left arm on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the patient had SARS-CoV-2 PCR test which was negative. On 29-MAY-2021, the patient had SARS COVID 2 antibody (Ab) Ig G semi-quantitative test which was negative (confirmed immunological vaccine failure). On 02-JUN-2021, the patient had SARS COVID 2 antibody (Ab) Ig G semi-quantitative tests again and which was negative.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint. The suspected product quality complaint has been confirmed to be not voided (meet PQC criteria) based on the PQC evaluation/investigation performed.; Sender's Comments: V0-20210613988-covid-19 vaccine ad26.cov2.s-confirmed immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
confirmed positive with self-antigen rapid testing on tuesday 24May; confirmed positive with self-antigen rapid testing on tuesday 24May; sore throat; Sniffles; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Lot number: EL3247), on 23Mar2021 as dose 2, single (Lot number: EL3247) and on 09Dec2021 as dose 3 (booster), single (Lot number: FF8839) at the age of 44 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHINORRHOEA (non-serious) with onset 23May2022, outcome "unknown", described as "Sniffles"; OROPHARYNGEAL PAIN (non-serious) with onset 23May2022, outcome "unknown", described as "sore throat"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 24May2022, outcome "unknown" and all described as "confirmed positive with self-antigen rapid testing on tuesday 24May". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24May2022) Positive, notes: confirmed positive with self antigen rapid testing on Tuesday 24May; (24May2022) Positive, notes: confirmed positive with self antigen rapid testing on Tuesday 24May.  Adverse event: Sniffles and sore throat on Monday 23May; confirmed positive with self antigen rapid testing on Tuesday 24May. Patient did not have covid prior vaccination and patient did not tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician and her first office staff member concerning a 4 year old patient who on 22-MAY-2008 was vaccinated with the second dose of VARIVAX (Merck) 0.5ml subcutaneously (lot# was either 660219/0154X or 660280/1997U). The patient developed swelling with warmth and redness from shoulder to elbow after receiving VARIVAX (Merck). Subsequently, the patient recovered. The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information is not expected.
Patient became extremely lethargic. Vision was very blurry. Blood pressure registered 89/64 with pulse of 72bpm.  Patient unable to move extremities
swelling erythema and warmth with pain to RUE in the area of the vaccine within 1 day. pt has similar but less severe reaction the year prior to same vaccine starting several days post vaccine
This spontaneous report received from a medical assistant referred to concerning a 20 months patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 02-MAY-2017, the patient received improperly stored dose of VARIVAX (dose, frequency not reported) (Lot: M041513, expiry date: 11-OCT-2018) reconstituted with sterile water diluent (unknown lot number and expiration date). No adverse effects reported. Temperature and Time frame: -14°C to -10°C for 9 hours 43 minutes, -14°C to -10°C for 15 hours 46 minutes, -14°C to -10°C for 12 hours 31 minutes. Previous temperature excursion was -14°C to -10°C for 6 hours 26 minutes. The call was because of data logger. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA014383: US-009507513-1706USA000288: US-009507513-1706USA000290: US-009507513-1706USA000291:
Customer stated she started feeling poorly three days after flu vaccine was administered.  Apparently her oxygen level dropped (customer suffers from COPD and other underlying health conditions).  Went to urgent care/hospital and underwent chest x-ray, some scans, blood work.  Covid was not detected and thought maybe she may have had a reaction to vaccine? Some of the blood work came back abnormal, however, customer could not give me specifics.
itching at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site). At the time of the report, INJECTION SITE PRURITUS (itching at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
incomplete vaccination administration due to operator error; less than half dose injected, pt was revaccinated with full dose in contralateral deltoid
Unusually painful menstrual cramps- have had consistent period for 15+ years but my first period post the vaccine was much more painful and the cramps lasted for days instead of hours.
This spontaneous report as received from a registered nurse refers to a 16 year old male patient. The patient's medical history was not reported. On 14-JUL-2015, the patient was vaccinated with the first dose of GARDASIL 9 lot # reported as K026247, expiration date reported as 29-JAN-2017 (dose, route and site of administration were not reported). No adverse effects were reported. Additional information has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 17-DEC-2017, the patient was inoculated with ZOSTAVAX by a health care provider as recommended for permanent prevention and protection against shingles and zoster-related conditions (dose, route, and lot # not provided). On an unknown date, the patient was diagnosed with shingles and/or other zoster-related injuries (Herpes zoster) after and despite being inoculated with the ZOSTAVAX. On an unknown date in 2017, the patient was treated by a health care provider for shingles (Herpes zoster). The lawyer reported that as a direct and proximate result of the ZOSTAVAX, the patient had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering, extensive medical care and treatment for these injuries, significant medical and related expenses because of these injuries; including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was unknown. Causality assessment was reported as related.
No adverse event; Patient received Moderna Covid-19 monovalent vaccine on 22-JUN-2022 which was expired in 27-MAR-2022; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 monovalent vaccine on 22-JUN-2022 which was expired in 27-MAR-2022) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 monovalent vaccine on 22-JUN-2022 which was expired in 27-MAR-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 monovalent vaccine on 22-JUN-2022 which was expired in 27-MAR-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 monovalent vaccine on 22-JUN-2022 which was expired in 27-MAR-2022).    No concomitant medication was reported.  Dosage text was reported as unknown. No treatment information was reported.  This case contains information for patient 6 out of 7.   This case was linked to US-MODERNATX, INC.-MOD-2023-731892 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-731892:Master case